4 citations
,
June 2023 in “Frontiers in Aging” The document explores the "middle-aging hypovascularity hypoxia hypothesis," which links age-related diseases to decreased vascularity and oxygenation during middle age. It emphasizes the role of hormonal signaling, particularly testosterone and estrogen, in reversing hypovascularity, and the impact of nitric oxide (NO) signaling on endothelial dysfunction. The hypothesis suggests that maintaining NO bioavailability through pathways like NO-cGMP could improve vasodilation and tissue oxygenation, potentially mitigating diseases such as type 2 diabetes, heart failure, and dementia. The review also discusses the testosterone–vascular–inflamm-aging triad, noting that declining testosterone levels can lead to vascular aging. It highlights the potential of PDE5 inhibitors and supplements like L-arginine and curcumin to improve vascular function. The document underscores the importance of understanding oxygen homeostasis and the role of hypoxia-inducible factor (HIF) in protecting against neurodegeneration, while also exploring translational imaging technologies to assess microcirculation changes related to aging.
24 citations
,
November 2015 in “Frontiers in Genetics” Nitroxide drugs can safely and effectively treat age-related diseases like macular degeneration and cardiovascular issues.
16 citations
,
November 2021 in “Antioxidants” Managing oxidative stress might help treat low testosterone and related chronic diseases in aging men.
December 2024 in “International Journal of Molecular Sciences” Human umbilical cord stem cell vesicles may help treat aging and related diseases.
122 citations
,
June 2020 in “Aging” Older age and related diseases increase COVID-19 risk, but anti-aging treatments might help.